185 related articles for article (PubMed ID: 556776)
1. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
Costall B; Naylor RJ
J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
[TBL] [Abstract][Full Text] [Related]
2. Aporphines. 14 Dopaminergic and antinociceptive activity of aporphine derivatives. Synthesis of 10-hydroxyaporphines and 10-hydroxy-N-n-propylnoraporphine.
Neumeyer JL; Reinhard JF; Dafeldecker WP; Guarino J; Kosersky DS; Fuxe K; Agnati L
J Med Chem; 1976 Jan; 19(1):25-9. PubMed ID: 942751
[TBL] [Abstract][Full Text] [Related]
3. Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.
Costall B; Naylor RJ; Neumeyer JL
Eur J Pharmacol; 1975 Mar; 31(1):1-16. PubMed ID: 1168579
[TBL] [Abstract][Full Text] [Related]
4. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
Jackson EA; Neumeyer JL; Kelly PH
Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
[TBL] [Abstract][Full Text] [Related]
5. Aporphines. 15. Action of aporphine alkaloids on dopaminergic mechanisms in rat brain.
Miller RJ; Kelly PH; Neumeyer JL
Eur J Pharmacol; 1976 Jan; 35(1):77-83. PubMed ID: 943290
[TBL] [Abstract][Full Text] [Related]
6. R(-) and S(+) stereoisomers of 11-hydroxy- and 11-methoxy-N-n-propylnoraporphine: central dopaminergic behavioral activity in the rat.
Campbell A; Baldessarini RJ; Gao Y; Zong R; Neumeyer JL
Neuropharmacology; 1990 Jun; 29(6):527-36. PubMed ID: 1974710
[TBL] [Abstract][Full Text] [Related]
7. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
[TBL] [Abstract][Full Text] [Related]
8. Altered spontaneous behavior and sensitivity to apomorphine in rats following pretreatment with S(+)-aporphines or fluphenazine.
Campbell A; Baldessarini RJ; Neumeyer JL
Psychopharmacology (Berl); 1993; 111(3):351-8. PubMed ID: 7870974
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
Campbell A; Baldessarini RJ; Ram VJ; Neumeyer JL
Neuropharmacology; 1982 Oct; 21(10):953-61. PubMed ID: 6890636
[TBL] [Abstract][Full Text] [Related]
10. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
Costall B; Naylor RJ; Neumeyer JL
J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
[No Abstract] [Full Text] [Related]
11. Synthesis and biological activity of some aporphine derivatives related to apomorphine.
Saari WS; King SW
J Med Chem; 1974 Oct; 17(10):1086-90. PubMed ID: 4472802
[No Abstract] [Full Text] [Related]
12. Aporphines. 16. Action of aporphine alkaloids on locomotor activity in rats with 6-hydroxydopamine lesions of the nucleus accumbens.
Kelly PH; Miller RJ; Neumeyer JL
Eur J Pharmacol; 1976 Jan; 35(1):85-92. PubMed ID: 1253829
[TBL] [Abstract][Full Text] [Related]
13. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
16. Differential activation by some 2-aminotetralin derivatives of the receptor mechanisms in the nucleus accumbens of rats which mediate hyperactivity and stereotyped biting.
Costall B; Naylor RJ; Cannon JG; Lee T
Eur J Pharmacol; 1977 Feb; 41(3):307-19. PubMed ID: 556988
[TBL] [Abstract][Full Text] [Related]
17. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL
Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445
[TBL] [Abstract][Full Text] [Related]
18. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL
Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830
[TBL] [Abstract][Full Text] [Related]
19. Aporphines as antagonists of dopamine D-1 receptors.
Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL
J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and potency comparisons among aporphine enantiomers: effects on dopamine neurons in substantia nigra of rat.
Martin LP; Cox RF; Waszczak BL
Neuropharmacology; 1990 Feb; 29(2):135-43. PubMed ID: 2184376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
